Hinge Health CEO Daniel Antonio Perez and CFO James Budge sold more than $27 million in company stock on September 10, 2026. Perez and his spouse disposed of shares valued at approximately $22.3 million. Budge sold shares totaling roughly $4.97 million.
The executives conducted these transactions under pre-arranged Rule 10b5-1 trading plans adopted in June 2026.
The sales coincide with Hinge Health shares trading near a 52-week high following a significant six-month rally. The company recently reported better-than-expected second-quarter earnings and raised its full-year guidance, prompting positive price target revisions from multiple analyst firms.